NKMax NYSE

Korean chipmakers Magnachip to sell display business in H1 to focus on power semiconductors

South Korean chipmaker Magnachip Semiconductor Corp. plans to sell its display business by the end of the first half as part of a strategic shift to...

IPOs South Korea’s Viva Republica drops Korean IPO plan, seeks US debut

Viva Republica Inc., a leading South Korean fintech unicorn and operator of mobile financial super app Toss, has dropped its plan to go public in th...

Artificial intelligence LG, Qraft Technologies' AI-powered ETF trades on NYSE

South Korea’s LG Group and Seoul-based Qraft Technologies Inc. have jointly launched an exchange-traded fund (ETF) that selects holdings relat...

Bio & Pharma NKMax to perform first tests on dementia cell therapy in US

NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...

Bio & Pharma NKMax's US subsidiary listed on Nasdaq

South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...

Bio & Pharma NKMax to supply health functional food to Chinese company

South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's S...

Bio & Pharma NKMax submits US subsidiary's securities report to SEC

The listing in the US of NKGen Biotech, the American subsidiary of South Korean developer of natural killer (NK) cell therapy NKMax Co., is coming i...

Bio & Pharma US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q

NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...

Bio & Pharma S.Korean biotech NKMax’s unit aims for US IPO

NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...

Batteries SK on eve of jackpot from NYSE debut of US battery maker SES

SK Inc., the investment-focused holding company of South Korea’s SK Group, is set to pocket a sixfold return from its investment in SES Holdin...

Korean stock market S.Korean millennials rush on Nasdaq and NYSE amid sluggish Kospi

South Korean millennials in their 20s and 30s are rushing to Nasdaq and the New York Stock Exchange (NYSE) amid skyrocketing real estate prices in t...

IPOs Coupang applies for IPO on New York Stock Exchange

Coupang Corp., 37% owned by SoftBank Group, is set to become the first Korean company to list directly on the New York Stock Exchange, with its valu...